---
schema_version: "secwatch.filing_event.v1"
accession: "0001384101-25-000010"
form_type: "8-K"
ticker: "VCYT"
cik: "0001384101"
company_name: "VERACYTE, INC."
filed_at: "2025-02-24T23:59:59+00:00"
generated_at: "2026-05-26T05:39:25.861190+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Veracyte Q4 revenue $118.6M (+21%), net income $5.1M vs. loss a year ago

## Summary
- Q4 total revenue $118.6M (+21%), testing revenue $112.2M (+24%), testing volume +25% to 39,107 tests.
- Q4 net income $5.1M vs. net loss in Q4 2023; adjusted EBITDA $26.1M (22.0% margin), up 76%.
- Full-year 2024 revenue $445.8M (+23%), net income $24.1M vs. 2023 loss; adj. EBITDA $91.9M (20.6%).
- Decipher revenue +44% in Q4, volume +45% to >22,400 tests; Afirma revenue +4%, volume +8%.
- Cash from operations $75.1M in 2024; ended with $289.4M cash & short-term investments.

## SEC filing metadata
- accession: 0001384101-25-000010
- form_type: 8-K
- ticker: VCYT
- cik: 0001384101
- company_name: VERACYTE, INC.
- filed_at: 2025-02-24T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1384101/000138410125000010/0001384101-25-000010-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1384101/000138410125000010/vcyt-20250224.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001384101-25-000010
- JSON: https://secwatch.observer/filing/0001384101-25-000010.json
- Plain text: https://secwatch.observer/filing/0001384101-25-000010.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.